Sign inJoin waitlistJoin the waitlist

Lewis R Silverman

Medical Oncology · Icahn School of Medicine at Mount Sinai

Credentials: · · ·

History

Montefiore Medical Center
Metropolitan Hospital Center
Montefiore Medical Center
Vrije Universiteit Brussels Faculte de Medecine

Research

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
The Lancet Oncology · 2009 · 2,176 citations
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B
Journal of Clinical Oncology · 2002 · First of 14 authors · Corresponding · 1,495 citations
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia
Journal of Clinical Oncology · 2010 · Last of 16 authors · 801 citations

SN
Shyamala Navada
14 papers
JH
James Holland
10 papers
John Mascarenhas
10 papers
SG
Steven Gore
10 papers
Guillermo Garcia-Manero
9 papers
AL
Alan List
8 papers
Jonathan Feld
8 papers
Douglas Tremblay
7 papers
CS
Charles Schiffer
6 papers
Richard Larson
6 papers
Ronald Hoffman
6 papers
Alla Keyzner
4 papers

Grants

Myeloproliferative Neoplasms-Research Consortium
National Cancer Institute · P01
Project lead · $10.4M · Icahn School of Medicine at Mount Sinai
2005–2017
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $9.5K · Icahn School of Medicine at Mount Sinai
2009
Cancer and Leukemia Group b--Mount Sinai
National Cancer Institute · U10
Contact PI · $98.3K · Icahn School of Medicine at Mount Sinai
1979–2003

Clinical trials

Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
Principal investigator · Completed · Phase 1
Traws Pharma, Inc.
2008–2015
Research Tissue Bank
Principal investigator · Completed
Icahn School of Medicine at Mount Sinai
2007–2017